ABBVIE BIOTHERAPEUTICS INC.;DANA-FARBER CANCER INSTITUTE, INC.
发明人:
AFAR, DANIEL,ANDERSON, KENNETH C.,TAI, YU-TZU
申请号:
HRP20150449
公开号:
HRP20150449T1
申请日:
2015.04.27
申请国别(地区):
HR
年份:
2015
代理人:
摘要:
Composition suitable for treating multiple myeloma in a subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.